Walgreens Commits $2.3 Mil. To Settle Pseudoephedrine Sale Complaint
This article was originally published in The Tan Sheet
Executive Summary
Walgreens agreed to a $1.3 mil. fee July 28 to settle government allegations that the company had violated state and federal laws regulating the sale of pseudoephedrine